Drug Discovery & Trials

13+ min ago   (227+ words) The Manila Times Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines Initial focus on prevalent metabolic dysfunctions where complex disease biology and overlapping comorbidities will…...

4+ week, 2+ hour ago   (747+ words) Phase I / Early Phase Phase II+ / Late Phase The North American Advantage Global scientific & regulatory affairs Global site partnership network As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable…...

1+ hour, 4+ min ago   (286+ words) October 15, 2026 15:00 ET | Source: Avance Clinical Avance Clinical AusBiotech International is one of the largest biotechnology gatherings in the Southern Hemisphere. In 2025 it drew participants from more than 23 countries. Avance Clinical says this international reach signals Australia's growing role as a…...

1+ hour, 1+ min ago   (188+ words) Structural biologist Nicolas Fawzi will direct Brown's role in a multi-institution project to transform the understanding of cellular protein dysfunction in the earliest stages of neurodegenerative disease. PROVIDENCE, R.I. [Brown University] - Brown University Professor of Molecular Biology, Cell Biology and Biochemistry…...

6+ hour, 5+ min ago   (554+ words) Genetic Engineering and Biotechnology News Scientists from the University of Toronto, the Sloan Kettering Institute, King’s College London, and the Francis Crick Institute have published data that points to a role for several new microexons in the development of autism…...

3+ week, 1+ day ago   (529+ words) Annovis Bio, Inc., a Malvern, Pennsylvania-based Phase 3 clinical-stage biotech, announced on September 23, 2026 a collaboration with Weave Bio, an AI platform for regulatory content and knowledge management, to support the planned New Drug Application (NDA) for buntanetap, its i Annovis Bio…...

3+ week, 6+ day ago   (581+ words) Kemp Proteins, LLC, a Frederick, Maryland-based gene-to-protein services provider, announced on September 17, 2026 a strategic partnership with NeuImmune to implement NeuImmune’s proprietary glycoengineered CHO (geCHO) BioDesign platform, giving Kemp greater control over pr Kemp Proteins Partners With NeuImmune to Bring Glycoengineered…...

1+ hour, 46+ min ago   (576+ words) AI isn’t sitting on the sidelines of life sciences anymore. It’s becoming a collaborator. Across Greater Philadelphia, the BioHealth Capital Region and North Carolina, pharma companies, academic medical centers, CDMOs and startups are teaming up with AI companies to tackle…...

6+ hour, 55+ min ago   (181+ words) TIME recognizes TBC's breakthrough in translating discoveries from living neurons into faster and more efficient AI models. SAN FRANCISCO, Oct. 15, 2026 /PRNewswire/ -- The Biological Computing Co. (TBC), an applied biological computing company, today announced that its neuron-derived technology, behind its first…...

3+ hour, 30+ min ago   (165+ words) Google DeepMind on October 15, 2026 published a technical walkthrough in which biologists used Google Antigravity, its agentic development platform, to identify a novel antimicrobial peptide candidate in Streptococcus pseudopneumoniae, and the company said the lead is undergoing wet-lab validation. Aria Bloom…...